tesamorelin cjc-1295 no dac ipamorelin 12mg blend 6/3/3 mg 1295 (Mod GRF 1 tesamorelin or ipamorelin dac cjc

KPV pre-empts the inflammation switch (NF-B) before it activates, so reactive skin doesnt drown the rebuilding signals

And they had to change that label and say, hey, not only is this only a fraction better than a placebo, right

Clinical data support their role in connective tissue synthesis, recovery efficiency, and fat-free mass gains when paired with resistance training

As of April 2026, CJC-1295 and Ipamorelin have been removed from the Food and Drug Administrations (FDA) Category 2 restricted list, with formal review of compounding eligibility scheduled for July 2026

Think of it as the release-side signal: trigger the actual GH pulse